A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer
| Status: | Archived |
|---|---|
| Conditions: | Cancer, Cancer, Pancreatic Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | May 2010 |
| End Date: | June 2013 |
A Study Evaluating Safety and Efficacy of Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Adenocarcinoma
The purpose of this study is to find out the effects, good and/or bad, of the combination of
two drugs, gemcitabine and bosutinib, in patients with resected pancreatic cancer and
whether this combination can prevent pancreatic cancer from coming back.
We found this trial at
2
sites
Click here to add this to my saved trials
1600 Divisadero Street
San Francisco, California 94115
San Francisco, California 94115
888.689.8273
UCSF Helen Diller Family Comprehensive Cancer Center UCSF’s long tradition of excellence in cancer research...
Click here to add this to my saved trials